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Abstract Atrial septal defect (ASD) is the most common
congenital cardiac lesion accounting for 10–15% of all
cardiac malformations. In the majority of cases, the
secundum type of the ASD is closed percutaneously in the
catheterization laboratory. Although transcatheter closure
of ASD is considered safe and effective in pediatric
patients, there are limited data regarding the efficacy and
safety of device ASD closure in smaller infants. The aim of
this study was to determine risk of complications within
72 h following device closure of ASD in children of body
weight \15 kg compared to larger children. Overall 252
children who underwent transcatheter closure of ASD at
Children’s Heart Centre in Lund, Sweden, between 1998
and 2015 were included. Data regarding demographics,
comorbidity and complications occurring during and after
device procedure until discharge were retrieved from the
hospital’s databases. Echocardiographic data were obtained
from the digital and videotape recordings. Nearly half of
the study cohort (n = 112; 44%) had a procedural weight
\15 (median 11.3) kg with a median procedural age of
2.02 years. Among this study group, 22 (9%) children had
post-procedural in-hospital complications, of which 16
(7%) were considered as major and six (2%) considered as
minor. No deaths occurred. There was no significant dif-
ference in of the occurrence of major or minor complica-
tions between the two groups (p = 0.32). Larger ASD was
more often associated with minor complications, OR 1.37
(95% CI 0.99–1.89), which most often consisted of tran-
sient arrhythmias during or after the procedure. Percuta-
neous ASD device closure can be performed safely in low-
weight infants with a risk of post-procedural in-hospital
complications comparable to larger/older children. Never-
theless, careful considerations of the indications to device
closure is needed, particularly in children with larger ASD,
as recommended by the current international guidelines for
ASD closure.
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Background
Cardiovascular malformations affect approximately 800
children per year in Sweden [1, 2]. Atrial septal defect
(ASD) is the most common congenital cardiac lesion
accounting for 10–15% of all cardiovascular malforma-
tions [2].
Larger ASD causes a significant left-to-right shunt with
subsequent volume load of the right side of the heart. If left
untreated, particularly in children with comorbidities,
changes in the pulmonary arterioles may lead to gradual
rise in the pulmonary pressure and eventually irreversible
arteriolar damage, which is known as Eisenmenger syn-
drome [3]. Surgery has been considered to be the standard
treatment of ASD ever since the late 1960s with good long-
term post-operative results [4, 5]. The first catheter-based
closure of secundum ASD was described by King and Mills
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in 1976 [6]. Transcatheter closure of ASD has gradually
become more common and has been associated with less
complications and shorter hospitalization [7, 8]. Today, the
transcatheter approach is considered safe and effective,
with few but non-negligible short- and long-term adverse
events [9].
Asymptomatic infants with a significant ASD shunt are
typically followed until they have grown to an accept-
able age and size. Recent guidelines recommend tran-
scatheter closure after the age of 2, although common
practice suggests a weight over 15 kg [10]. Symptomatic
infants, such as those born prematurely, with failure to
thrive or with additional comorbidity or need for respira-
tory support, may benefit from early ASD closure in order
to improve their clinical status [11, 12]. Refinements in the
device configuration and material used during catheteri-
zation have contributed to improved procedural safety even
in small children with severe clinical picture [13, 14]. In
older children and adults, increased ratio of the ASD
diameter/weight ratio and deficient or absent aortic rim
have been associated with increased frequency of adverse
events following transcatheter ASD closure [15, 16]. Pre-
vious studies on the efficacy and safety in children with
small body weight have focused on risk factors such as
ASD size, procedural body weight and age [13, 14, 17, 18].
However, other factors such as cardiac and other comor-
bidity, genetic abnormalities, premature birth and pul-
monary function including chronic lung disease (CLD)
may influence the risk of in-hospital adverse complications
following ASD device closure.
The aim of this study was to assess the risk of major and
minor complications following percutaneous transcatheter
device closure of ASD in children with procedural weight
\15 kg compared to larger children. Other potential risk
factors such as cardiac and other comorbidities including
premature birth were also taken into account.
Study Population and Methods
All children under the age of 18 years who underwent
transcatheter ASD closure between 1998 and 2015 at the
Ska˚ne University Hospital in Lund, Sweden, were included
in the study. Demographic information, such as age and
weight at procedure, gestational age at birth and type of
device, as well as information on complications and
comorbidity was retrieved from medical records, from the
Swedish Registry for Congenital Heart Disease (SWED-
CON) and from the Swedish National Birth Registry
(MFR) [19, 20]. MFR was established in 1973 and includes
data on more than 99% of all births in Sweden [21].
Information on ASD size was retrieved from echocardio-
graphic examinations. Comorbidity, including other
cardiac defects, genetic abnormalities and other diseases, is
retrieved from medical journals and classified according to
Table 1. Gestational age was estimated by ultrasonic pre-
natal examination and retrieved from MFR register. Pre-
mature birth was defined as birth at\37 gestational weeks.
Echocardiography
Echocardiographic data were retrieved from stored video-
tapes and digital examinations. The largest diameter of the
ASD was measured from transesophageal echocardiogra-
phy (TEE) images, being expressed in millimeter. All
measurements were made by two investigators with
intraobserver and interobserver variability of 3.0 and 2.7%,
respectively.
The following indices were used:
1. The ASD diameter/weight ratio was calculated using
the largest measured ASD diameter (from TEE)
divided by the child’s weight at the procedure. The
children were thereafter categorized in two groups
using a cutoff ratio of 1.2. This value was earlier
shown to be a risk factor for post-procedural compli-
cations [15, 18].
2. The ASD diameter/BSA ratio was calculated using the
largest measured ASD diameter (from TTE) divided by
the child’s BSA at the procedure. The body surface
area (BSA) was calculated using Haycock geometrical
formula [22].
Post-procedural complications were grouped into minor
and major complications according to Bartakian et al. [17]. All
complications occurring within the first 72 h after procedure
or before discharge are classified and described in Table 2.
Statistical Analyses
Demographic data were analyzed using Student’s t test
(unpaired two-sided) for parametrically distributed variables
and Mann–Whitney U test for nonparametric distributed
variables with a p value of\0.01 and Chi-squared test with a
p value of\0.05 considered as statistically significant.
Demographic data are presented as mean and standard
deviation (Std.) for parametric variables and as median and
range for nonparametric variables.
Conditional logistic regression was preformed to eval-
uate the association between major and minor complication
for children \15 kg at procedure and premature birth,
cardiac and non-cardiac comorbidities, chromosomal
abnormalities, ASD size, ASD diameter-to-weight ratio,
BSA and ASD diameter-to-BSA ratio. Maximum likeli-
hood estimates of the odds ratio (OR) and 95% confidence
interval (CI) were obtained, taking into account potential
confounding factors. The IBM SPSS Statistics, version 23
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software (IBM Corporation, New York, USA), was used to
fit the conditional logistic model.
The study was approved by the Ethics Committee for
Human Research at the Lund University (D-nr 2015/559)
in accordance with the ethical standards as laid down in the
1964 Declaration of Helsinki and its later amendments or
comparable ethic standards.
Results
In total, 252 children underwent ASD device closure at the
Ska˚ne University Hospital in Lund between 1998 and
2015. Their mean age was 5.36 (Std. 4.44) years, median
weight was 15.60 (range 4.78–87.50) kg, and the mean
ASD size was 12.15 mm (Std. 4.31 mm). The overall
female-to-male ratio was 1.7:1. The demographic charac-
teristics are shown in Table 3.
Of these, 112 (44%) children had a procedural weight of
\15 kg. Children B15 kg had a median weight of 11.30
(range 4.78–14.80) kg, whereas children [15 kg had a
median weight of 23.50 (range 15.00–87.50) kg. Children
B15 kg were younger with a mean age of 2.02 (Std.
1.00) years compared to children[15 kg with mean age of
8.03 (Std. 4.33) years (p\ 0.00).
The overall comorbidity was present in 65 (26%) chil-
dren. This included other cardiac defects in 22 (9%) chil-
dren, genetic comorbidity in 25 (10%) and other in 31
Table 1 Classification of comorbidity
Cardiac lesion Genetic Other
Pulmonary stenosis requiring treatment Down syndrome and other trisomies Cystic fibrosis
Pulmonary stenosis moderate/mild Monosomies, translocations, deletions Sickle cell anemia
Pulmonary stenosis, mild Combinations of monosomy, deletions, trisomies Omphalocele
Ventricular septal defect requiring treatment Osler’s disease
Double outlet right ventricle Muscular dystrophy
Transposition of great arteries Diabetes type 1
Aortic coarctation Bronchopulmonary dysplasia
Patent ductus arteriosus requiring treatment Atrioventricular block




Table 2 Classification of complications
Major complications Minor complications
Death Deployment malfunction
Cardiac or/respiratory arrest Suspected infection
Stroke Bleeding not needing transfusion
Device erosion Significant access site hematoma
Device embolization Prolonged transient limb paresthesia
Permanent limb injury Transient hypoxia during procedure
Need for emergent surgical procedure Trivial pericardial/pleural effusion
Persistent therapy-requiring arrhythmias




New valvular insufficiency/pulmonary vein obstruction
Bleeding needing transfusion
Pulmonary hypertension crisis
Discharge later than 24-h post-closure
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(12%). Comorbidity was more frequent 42 (38%) in the
group of children B15 kg compared to 23 (16%) in children
[15 kg (p\ 0.001). In total, 42 (17%) children were born
preterm. Data on gestational week at birth were missing in
36 cases (14%), as these children were born abroad. Data
on comorbidity are summarized in Table 4.
The Amplatzer septal occluder was the most common
type of device used (n = 212). Other devices included
Gore Occluder (n = 20), Cocoon/Vascular Innovations
(n = 8), Occlutech Figulla Flex (n = 7), Cardioseal
(n = 4) and Cardia Atriasept (n = 1).
Major complications were more common than minor
complications, especially in the group of children B15 kg.
The type of complications in each group and in all children
is shown in Table 5.
Echocardiography
ASD mean size by TEE was significantly smaller in
children B15 kg 10.97 mm (Std 3.40 mm) compared to
ASD size in children [15 kg 13.05 mm (Std. 4.72 mm)
(p\ 0.00). Also the device used was smaller 15.49 mm
(Std. 4.83 mm) in children B15 kg compared to
20.07 mm (Std. 6.96 mm) in the other group (p\ 0.000)
(Table 4).
Post-procedural Complications
Post-procedural in-hospital complications occurred in 22
(9%) children. There were no in-hospital deaths. Major
complications occurred in 16 (7%) children, whereas minor
Table 3 Demographic
characteristics of all children
n (%) Mean Median Std. Min–Max
Weight (kg) 252 – 15.6 15.32 4.78–87.50
Age (years) 252 5.36 – 4.44 0.33–17.79
TEE ASD size (mm) 221 12.15 – 4.31 4.00–24.00
Gestational age 216 – 39 3.56 23.70–43.10
Device size 252 18.04 – 6.51 5.00–36.00
ASD/weight ratio (mm/kg) 221 0.70 0.42 0.13–2.53
ASD/BSA ratio (mm/m2) 221 18.33 – 9.12 3.20–53.34
Table 4 Demographic information in each subgroup
B15 kg [15 kg
n (%) Mean Median Std. Min–Max n (%) Mean Median Std. Min–Max p
Weight (kg) 112 – 11.30 2.48 4.78–14.80 140 – 23.50 16.19 15.00–87.50 \0.00
Age (years) 112 2.02 – 1.00 0.33–5.15 140 8.03 – 4.33 2.34–17.79 \0.00
TEE ASD size (mm) 96 10.97 – 3.40 5.00–21.00 125 13.05 – 4.72 4.00–24.00 \0.00
Gestational age 103 – 39.29 3.78 23.70–43.1 113 – 38.78 3.36 24.70–43.00 0.95
Device size 112 15.49 – 4.83 6.00–33.00 140 20.07 – 6.96 5.00–36.00 \0.00
ASD/weight ratio (mm/kg) 96 – 1.00 0.39 0.42–2.53 125 – 0.47 0.26 0.13–1.27 \0.00
ASD/BSA ratio (mm/m2) 96 24.76 – 8.61 9.73–53.34 125 13.39 – 5.86 3.20–30.29 \0.00
Comorbidity Chi 2
Cardiac 13 (12) 9 (6) 0.15
Genetic 18 (16) 7 (5) \0.00
Other 21 (19) 10 (7) 0.01
Preterm birth 24 (23) 18 (16) 0.17
Device
Amplatzer 90 122
Gore occluder 11 9
Cardioseal 1 3
Occlutech figulla flex 4 3
Cocoon/vascular innovations 6 2
Cardia atriasept – 1
Significance p\ 0.05
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complications occurred in six (2%) children, all on the first
post-procedural day.
Major complications occurred in 11 (10%) children of
B15 kg weight, compared to six (4%) children of[15 kg,
with significant difference between the groups (p = 0.04).
Minor complications occurred in one (1%) among children
of B15 kg weight, compared to six (4%) among children of
[15 kg, with no significant difference between the groups
(Table 6).
The majority of children (n = 242 (96%)) were dis-
charged the day after the intervention. Six children were
discharged within 1 week and 3 children within 2 weeks.
One child was discharged 299 days after the ASD closure.
Among children with late discharge, five suffered from post-
procedural in-hospital complication (four major and one
minor) and one child had fatal device erosion out of hospital
5 days after the procedure. In three of these children, there
was no recorded post-procedural in-hospital complication.
Down syndrome was present in 1 child, with a previous
coarctation of the aorta, pulmonary hypertension and per-
sistent ductus arteriosus, which delayed this patient from
discharge. The child was hospitalized prior to the ASD clo-
sure due respiratory failure caused by a combination of
congestive heart failure and pneumonia. By the time of
intervention, the respiratory problems had resolved, and the
delayed discharged was due to feeding support. One other
child with chromosome 8 deletion, anal atresia, spherocy-
tosis and respiratory failure needed continuous positive air-
way pressure and oxygen treatment 19 days prior to the ASD
closure. After ASD closure, the respiratory support was
continued and the child was extubated 26 h after the inter-
vention. One child born preterm was discharged after
299 days of hospitalization. Prolonged hospitalization was
mainly due to complex feeding, respiratory and neurological
Table 5 Type of complications
in each subgroup and in all
children
B15 kg [15 kg All
Numbers of patients 112 (44%) 140 (56%) 252 (100%)
Major complications 11 (10%) 5 (4%) 16 (7%)
Need for emergent surgical procedure 2 (2%) 2 (1%) 4 (2%)
Arrhythmias requiring treatment 1 (1%) 1 (1%) 2 (1%)
Bleeding requiring transfusion 2 (2%) 0 2 (1%)
Pulmonary hypertension crisis 1 (1%) 0 1 (1%)
Blood pressure drop requiring treatment 1 (1%) 0 1 (1%)
Time to discharge[24 h 4 (4%) 1 (1%) 5 (2%)
Prolonged arrhythmias or potentially lethal
events during procedure
0 1 (1%) 1 (1%)
Minor complications 1 (1%) 5 (4%) 6 (2%)
Arrhythmias not needing treatment 4 (3%) 4 (12%)
Bleeding not needing transfusion 1 (1%) 1 (1%)
Blood pressure drop 1 (1%) 1 (1%)
Significant p values are given in italic (p\ 0.05)
Table 6 Risk factors for major
and minor complications
Number of major complications (n = 16) No Yes Total Chi-Square
Weight B15 kg 101 (90%) 11 (10%) 112 0.04
Comorbidity 57 (88%) 8 (12%) 65 0.02
Cardiac comorbidity 19 (87%) 3 (14%) 21 0.14
Genetic comorbidity 21 (84%) 4 (16%) 25 0.04
Other comorbidity 27 (87%) 4 (13%) 31 0.11
Preterm 39 (93%) 3 (7%) 42 0.62
Number of minor complications (N = 6)
Weight B15 kg 111 (99%) 1 (1%) 112 –
Comorbidity 64 (99%) 1 (%) 65 –
Cardiac comorbidity 22 (100%) 0 22 –
Genetic comorbidity 22 (100%) 0 22 –
Other comorbidity 31 (100%) 0 31 –
Preterm 42 (100%) 0 42 –
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problems resulting in need of mechanical ventilation, tra-
cheostomy and other care actions. One other child who was
born preterm stayed more than 72 h in hospital following
ASD device closure, due to severe respiratory problems
related to tracheobronchomalacia. During this time, the child
underwent tracheostomy and continuous mechanical venti-
lation. This child was also treated for multiple problems for
months pre-intervention. Further, the child was treated for a
suspected endocarditis, with a total hospital stay at several
centers after the ASD closure of 299 days.
There was no significant association between any of the risk
factors and major complication following ASD device closure.
Neither was low weight, OR = 1.67 (95% CI 0.38–7.30), ASD
diameter/weight ratio, OR = 0.92 (95% CI 0.13–6.63), nor
ASD diameter/BSA ratio, OR = 1.05 (95% CI 0.96–1.16)
associated with an increased risk of major complications in
multivariate analysis (Table 7). An increased risk of minor
complications was close to significant associated with a larger
ASD size, OR = 1.37 (95% CI 0.99–1.89), after adjustments
for confounding factors (Table 7).
Discussion
Our retrospective survey of a large cohort of children with
device closure of the ASD indicates a relatively low rate of
early post-procedural complications in those weighing
\15 kg. The risk of complications in this cohort of patients
was not altered by the presence of additional comorbidity
or large ASD size.
We found an overall post-procedural in-hospital com-
plication rate of 8.7%, with 9.8% in the group of children
of B15 kg compared to 7.1% among children of[15 kg,
but no significant difference between the groups. This is in
line with previous studies on complications following
percutaneous ASD closure [9, 17].
In children B15 kg at the procedure, major complica-
tions were more frequent (10%) compared to children
[15 kg (4%) at the procedure. However, we included
discharge from hospital later than 24 h as a major com-
plication, which accounted for 5 cases in our study. These
children suffered from severe pre-procedural medical
conditions and needed longer post-procedural care, unre-
lated to the device intervention. A complex medical history
prior to ASD closure may thus lead to longer hospital stay
and to several non-procedural-related complications such
as feeding support and respiratory support. When exclud-
ing discharge later than 24 h as a major complication after
ASD closure, the overall complication rate for the total
study group dropped to 6.3% and the rate of major com-
plications to 4.3%. This is in line with other studies [17].
Comorbidity was more common among children of B15 kg
compared to children [15 kg. In four cases, a prolonged
hospital stay post-intervention was associated with the
Table 7 Risk of complications




OR p value 95% Cl OR p value 95% Cl
Weight B15 kg 0.24 0.20 0.03–2.31 2.94 0.05 0.99–8.73
ASD/BSA 0.93 0.34 0.81–1.08 1.08 \0.00 1.03–1.13
BSA 6.31 0.01 1.52–25.33 0.37 0.37 0.08–1.63
ASD/weight[1.2 0 – – 4.18 0.02 1.31–13-35
Gestational age 0.99 0.94 0.76–1.29 0.96 0.60 0.83–1.11
ASD size 1.14 0.01 1.09–1.90 0.98 0.69 0.86–1.11
Device size 1.13 0.03 1.1–1.27 0.99 0.70 0.90–1.07
Card comorb 0 – – 2.34 0.16 0.69–10.01
Gen comorb 1.85 0.58 0.20–16.50 3.41 0.05 1.01–11.53
Other comorb 0 – – 2.57 0.12 0.77–8.53
Multivariate
Weight B15 kg 0 – – 1.67 0.50 0.38–7.30
ASD size 1.37 0.05 0.99–1.89 –
BSA 1.64 0.72 0.12–23.39 –
Device size 0.96 0.72 0.78–1.19 –
ASD/BSA – 1.05 0.30 0.96–1.16
ASD/weight[1.2 – 0.92 0.93 0.13–6.63
Card comorb – 2.13 0.32 0.48–9.50
Gen comorb – 1.91 0.35 0.50–7.30
Other comorb – 2.09 0.28 0.55–7.97
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compounded comorbidity. However, when recalculating
complication frequencies without using prolonged hospital
stay post-intervention as an event no significant difference
in the frequencies of major complications was found.
Higher ASD diameter/weight ratio and ASD-to-device
size ratio have been earlier associated with greater risk of
peri-procedural complications [15, 18]. In our study, we
adjusted risk estimations for minor as well as major com-
plications for these and other potential risk factors. The
ASD size and device size were larger among children
[15 kg in our study. The ASD size-to-body weight ratio
was doubled among the smaller children compared to those
[15 kg. Neither ASD diameter/weight ratio nor ASD
diameter/BSA ratio was associated with an increased risk
of major or minor complications in our study. However, the
risk of minor complications increased with larger ASD
size, and this association remained near significant after
adjustments for other risk factors OR = 1.37 (95% CI
0.99–1.89). No such risk was noticed for major complica-
tions. Increased frequency of minor complications, such as
transient arrhythmias, following percutaneous closure of
larger ASD ([15 mm) has been reported by others [23].
Altogether, four children in our study were identified with
procedural-related arrhythmias, which did not need
treatment.
A previous study concluded that device closure of ASD
[20 mm in children\20 kg is safe with regard to the risk
of major complications [24]. We performed subgroup
analysis of the risk of in-hospital complication after closure
of ASD[20 mm. Overall 14 (6%) children and only one
(1%) child of B15 kg had an ASD diameter larger than
20 mm. The risk of post-procedural minor complications
for these children was associated with OR = 44.87 (95%
CI 2.29–877.95, p = 0.012) after adjustments for potential
confounders. Even though this accounted for a small group
of patients, the risk of minor complications indicated that
careful intra- and post-procedural monitoring of these
children is needed.
Most of the minor complications in our study were
intraprocedural arrhythmias. Thus, our study supports the
hypothesis that a combination of abnormally stretched atrial
wall decreased myocardial mass and edema due to a large
device may trigger transient arrhythmias [24, 25]. ASD is
known to alter the atrial depolarization as well as the struc-
ture of the atria with increased risk of arrhythmias [26, 27].
Although closing the ASD may reduce the prevalence of
atrial tachyarrhythmia [28], transient arrhythmias including
supraventricular tachycardia, ectopy and atrioventricular
block have been described following ASD closure.
Spontaneous closure of ASD\8 mm is known to occur
during the first years of infancy, but some ASD may
enlarge over time [29]. In our study, the cohort of children
of B15 kg (ASD size 5–21 mm) might include some ASDs
with a potential of spontaneous closure later in life.
However, all children included in the study had right heart
enlargement as sign of significant ASD shunt, so this
possibility is less likely.
In our study, comorbidity was more common among the
smaller children, which is in agreement with others [23].
Genetic abnormalities, including Down syndrome, was also
more common among the smaller children in our study,
16% of children B15 kg compared to 5% of children
[15 kg. Neither genetic nor cardiac comorbidity was
associated with increased risk of complications. Down
syndrome is known to increase risk of pulmonary hyper-
tension as well as heart failure in the presence of shunt
defects [30, 31]. The incidence of ASD among children
with Down syndrome is 8–48% [32]. In our study, 15 (6%)
of all children had Down syndrome.
Several earlier studies have showed that children suf-
fering from Down syndrome with compound cardiovas-
cular malformations may benefit from corrective surgery of
ASD [31, 33, 34]. Our study indicates that percutaneous
ASD closure can be preformed safe, but the patients with
Down syndrome were few and larger studies are needed.
Cardiovascular malformations are twice as common
among preterm infants compared to full-term infants and
have an increased mortality rate [35, 36]. The overall
incidence of ASD among prematurely born infants is
unknown, but a delayed spontaneous closure of ASD has
been noted [36]. In our study, 17% of all infants with ASD
percutaneous closure were born preterm and occurred
among the children B15 kg (23%) compared to those of
[15 kg (16%), with nonsignificant difference between the
groups. Larger studies are needed to determine the risk of
ASD device closure among preterm born children.
Prematurely born infants may suffer from severe pul-
monary complications in association with ASD and pul-
monary hypertension even as adults [12, 37–39]. Thus,
prematurely born children may benefit from early percu-
taneous treatment to eliminating the left-to-right shunt
[12, 37–39]. Prematurity was not a risk factor in our study
for neither minor nor major complications, indicating that
prematurely born infants can be considered for percuta-
neous closure of ASD. Even if ASD closure is safe for
prematurely born infants, longer follow-up studies are
needed to determine the long-term safety and benefits of
early ASD closure.
Our study is limited by its retrospective nature. Data are
collected from medical journals, registers and echocardio-
graphic examinations, and thus, there is a risk of selection
bias and missing data. To reduce these risks, all echocar-
diographic data were retrieved by only two researches with
very low intraobserver and interobserver variability. Fur-
ther, the number of included children is substantial, con-
tributing increased power.
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Using already assigned entities of complications to either
major or minor categories may strengthen the study in
comparison with other. Lund is one of the three centers in
Sweden where percutaneous treatment of ASD is performed.
During the study period, only 3 interventionists preformed
all ASD closures. This minimizes risk of selection bias due to
different techniques and interventionist skills.
Conclusion
ASD closure in most infants with a bodyweight of below
than 15 kg or less can be performed safely with a low risk
of post-procedural in-hospital complications, but consid-
erations due to non-negligible complications can occur and
sufficient indication to benefit the closure in small infants
must be carefully considered. Increased risk of minor
complications after ASD closure was associated with an
increasing size of ASD. Further studies are needed to
establish the long-term safety of ASD closure via device on
low-weight children with potential risk factors such as
prematurity, cardiac and other comorbidities.
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